Dipeptidyl peptidase-4 inhibitors and cardiovascular and renal disease in type 2 diabetes: What have we learned from the CARMELINA trial?

Nordin M.J. Hanssen, Karin A.M. Jandeleit-Dahm

Research output: Contribution to journalReview ArticleResearchpeer-review

19 Citations (Scopus)
Filter
Finished

Search results